Recoly n.v. – product pipeline review – 2012


Published on

2012 || Recoly N.V. – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Recoly n.v. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Recoly N.V. – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Recoly N.V. - Product PipelineReview - 2012” provides data on the Recoly N.V.’s research and development focus.The report includes information on current developmental pipeline, complete withlatest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Recoly N.V.’s corporate website, SEC filings, investorpresentations and featured press releases, both from Recoly N.V. and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- Recoly N.V. - Brief Recoly N.V. overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Recoly N.V. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe
  2. 2. Table of contents:List of Tables 3List of Figures 3Recoly N.V. Snapshot 4Recoly N.V. Overview 4Key Information 4Key Facts 4Recoly N.V. – Research and Development Overview 5Key Therapeutic Areas 5Recoly N.V. – Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products – Monotherapy 8Recoly N.V. – Pipeline Products Glance 9Recoly N.V. – Late Stage Pipeline 9Registration Filed Products/Combination Treatment Modalities 9Recoly N.V. Clinical Stage Pipeline Products 10Phase II Products/Combination Treatment Modalities 10Recoly N.V. – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11Recoly N.V. – Drug Profiles 12NecLip-G-CSF 12Product Description 12Mechanism of Action 12R&D Progress 12NecLip-pdFVIII 13Product Description 13Mechanism of Action 13R&D Progress 13NecLip-rFVIIa 14Product Description 14Mechanism of Action 14R&D Progress 14REC-200-Liposomal Glucocorticoid 15Product Description 15Mechanism of Action 15R&D Progress 15
  3. 3. Recoly N.V. – Pipeline Analysis 16Recoly N.V. – Pipeline Products by Therapeutic Class 16Recoly N.V. – Pipeline Products By Target 17Recoly N.V. – Pipeline Products by Route of Administration 18Recoly N.V. – Pipeline Products By Mechanism of Action 19Recoly N.V. – Locations And Subsidiaries 20List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Proteo, Inc. – Product Pipeline Review – 2012Reata Pharmaceuticals, Inc. – Product Pipeline Review – 2012Recoly N.V. – Product Pipeline Review – 2012S.L.A. Pharma AG – Product Pipeline Review – 2012SBI Biotech Co., Ltd. – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012SIFI Pharma – Product Pipeline Review – 2012
  4. 4. Snowdon Inc. – Product Pipeline Review – 2012Stelic Institute & Co. – Product Pipeline Review – 2012SWITCH Biotech LLC – Product Pipeline Review – 2012Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012TetraLogic Pharmaceuticals – Product Pipeline Review – 2012Tranzyme Pharma, Inc. – Product Pipeline Review – 2012Unigene Laboratories, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :
  5. 5. Aarkstore EnterpriseLavanyaPhone:08149852585Email: